RT Journal Article
SR Electronic
T1 Estimating the effect of physical distancing on the COVID-19 pandemic using an urban mobility index
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.05.20054288
DO 10.1101/2020.04.05.20054288
A1 Soucy, Jean-Paul R.
A1 Sturrock, Shelby L.
A1 Berry, Isha
A1 Daneman, Nick
A1 MacFadden, Derek R.
A1 Brown, Kevin A.
YR 2020
UL http://medrxiv.org/content/early/2020/04/07/2020.04.05.20054288.abstract
AB Governments around the world are implementing population-wide physical distancing measures in an effort to control transmission of COVID-19, but metrics to evaluate their effectiveness are not readily available. We used a publicly available mobility index based on the relative frequency of trips planned in a popular transit application to evaluate the effect of physical distancing on infection growth rates and reproductive number in 34 states and countries. We found that a 10% decrease in relative mobility in the 2nd week of March was associated with a 11.8% relative decrease (exp(ϐ) = 0.882; 95% CI: 0.822, 0.946) in the average daily growth rate in the fourth week of March and a change in the instantaneous reproductive number of −0.054 (95% CI: 0.097, −0.011) in the same period. Our analysis demonstrates that decreases in urban mobility were predictive of declines in epidemic growth at national or sub-national scales. Mobility metrics offer an appealing method to calibrate population-level physical distancing policy and implementation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study used exclusively publicly available data. Sources are listed in the supplemental tables.